RAPP insider trading: Rapport Therapeutics, Inc.
Open-market insider purchases and sales of Rapport Therapeutics, Inc. reported on SEC Form 4 in the last 180 days (48-hour delay): 1 buys totaling $144K and 7 sales totaling $562K.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 79 | RAPP | Rapport Therapeutics, Inc. | Ignelzi Troy A. | CFO | 2026-10-21 | $144K | 55% | 6 insiders |
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-07 | Ceesay Abraham | CEO | $35K | yes |
| 2026-10-06 | Ceesay Abraham | CEO | $108K | yes |
| 2026-09-30 | Gault Cheryl | Officer | $262K | yes |
| 2026-09-30 | Gault Cheryl | Officer | $70K | yes |
| 2026-09-23 | Ceesay Abraham | CEO | $76K | yes |
| 2026-09-23 | Ceesay Abraham | CEO | $9K | yes |
| 2026-09-23 | Ceesay Abraham | CEO | $2K | yes |
Get new filings the morning after: daily alerts. Not investment advice.